Sonoma Pharmaceuticals (SNOA) Non-Current Assets (2011 - 2025)

Sonoma Pharmaceuticals' Non-Current Assets history runs 15 years deep, the most recent figure standing at $1.5 million for Q4 2025.

• In Q4 2025, Non-Current Assets rose 14.75% year-over-year to $1.5 million; the TTM figure through Dec 2025 stood at $5.4 million (down 19.81% YoY), while the FY2025 annual figure was $1.0 million, down 52.33% from the prior year.
• Non-Current Assets was $1.5 million for Q4 2025 at Sonoma Pharmaceuticals, up from $1.4 million in the prior quarter.
• In the past five years, Non-Current Assets ranged from a high of $2.7 million in Q4 2022 to a low of $1.0 million in Q1 2025.
• Historically, Non-Current Assets has averaged $1.9 million across 5 years, with a median of $2.0 million in 2021.
• The sharpest annual moves came in 2022 and 2025: Non-Current Assets soared 63.59% in 2022, then plunged 52.33% in 2025.
• A 5-year view of Non-Current Assets shows it stood at $1.6 million in 2021, then surged by 63.59% to $2.7 million in 2022, then dropped by 21.51% to $2.1 million in 2023, then slumped by 39.13% to $1.3 million in 2024, then grew by 14.75% to $1.5 million in 2025.
• The last three Non-Current Assets figures came in at $1.5 million (Q4 2025), $1.4 million (Q3 2025), and $1.5 million (Q2 2025), per Business Quant data.